Recombinant Human MAP2K7 / MEK7 Protein，His

MAP2K7, also known as JNK kinase or MKK7, is a vital component of the mitogen-activated protein kinase (MAPK) signaling cascade, specifically involved in the activation of c-Jun N-terminal kinases (JNKs). This pathway plays a crucial role in cellular responses to various stress stimuli, including inflammation, apoptosis, and cell proliferation. Due to its significant involvement in these processes, MAP2K7 has garnered considerable interest in cancer research, neurodegenerative diseases, and other pathologies. Studies have shown that dysregulation of the MAPK pathway, including MAP2K7, is linked to tumor progression and metastasis, making it a potential target for therapeutic interventions. The recombinant expression of MAP2K7 allows for in-depth studies of its biochemical properties, substrate interactions, and regulatory mechanisms. Furthermore, producing MAP2K7 as a recombinant protein facilitates the exploration of its role in various signaling pathways under controlled experimental conditions. This, in turn, aids in understanding its functional implications in health and disease, leading to potential approaches for targeted therapies. Understanding the structure-function relationship of MAP2K7 through recombinant protein studies may open new avenues for drug design, particularly in targeting specific pathways influenced by JNK signaling in diseases such as cancer and chronic inflammatory conditions. Overall, the investigation of recombinant MAP2K7 holds the promise of elucidating its precise biological roles and therapeutic potential in various diseases.